MedTrace Logo

BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus

NCT07070089 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-04-15

No results posted yet for this study

Summary

This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.

Conditions

  • Pulsatile Tinnitus
  • Venous Sinus Stenosis

Interventions

DEVICE

BosSTENT implantation

BosSTENT implantation in the transverse venous sinus

Sponsors & Collaborators

  • Sonorous NV, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2027-07-31
Completion
2028-07-31

Countries

  • Canada
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07070089 on ClinicalTrials.gov